1672-2809
2015 Issue 4
Updates of New Molecular Entities Approved by FDA in 2014：Cardiovascular Diseases, Pulmonary Diseases and Diabetes
SUN Shu-sen;,MA Xiang;,Zhao Zhi-gang;
SUN Shu-sen;,MA Xiang;,Zhao Zhi-gang;
..............page:5-10,13
Discussion on Clinical Pharmacists from the Section Wheel to the Necessity of the Specialized Training
Shu Wen-lin;,Zheng Zhong-jian;
Shu Wen-lin;,Zheng Zhong-jian;
..............page:11-13
Analysis of the Use of Antithrombotic Agents Added to the National Essential Drugs List (2012 version)
FENG Sheng-min;,ZHANG Xing-guo;
FENG Sheng-min;,ZHANG Xing-guo;
..............page:14-17
The Application and Development of Biomarkers in Breast Cancer
HUO Ji-ping;,ZHAO Zhi-gang;
HUO Ji-ping;,ZHAO Zhi-gang;
..............page:18-23
The Comparison between Novel Oral Anticoagulants and Warfarin in Clinical Application
GUO Meng-yuan;,ZHAO Zhi-gang;,SUN Shu-sen;,LI Xin-gang;
GUO Meng-yuan;,ZHAO Zhi-gang;,SUN Shu-sen;,LI Xin-gang;
..............page:24-29
Studies on the Interaction between Oxaliplatin and Lysozyme by Fluorescence Spectrometry
CHEN Chen;,ZHANG Hong-feng;,WANG Le;,WEI Ya-chao;
CHEN Chen;,ZHANG Hong-feng;,WANG Le;,WEI Ya-chao;
..............page:30-33
..............page:34-37
..............page:37-37
Clinical Pharmacist Participating in Ischemic Stroke Treatment for a Patient
GAO An-na;,WANG Rong-rong;,RAO Yue-feng;,YE Zi-qi;
GAO An-na;,WANG Rong-rong;,RAO Yue-feng;,YE Zi-qi;
..............page:38-39,47
A Case of Drug-Related Lung Damages Induced by Imatinibmesylate
MU Wei-jing;,REN Xiao-lei;,ZHANG Li;,LIU yi;,ZHANG Hai-ying;
MU Wei-jing;,REN Xiao-lei;,ZHANG Li;,LIU yi;,ZHANG Hai-ying;
..............page:40-42
..............page:42-42
..............page:43-44
One Case of High-dose of Norethisterone Induced Retinopathy
LIU Rui-ning;,YIN Yan-chun;
LIU Rui-ning;,YIN Yan-chun;
..............page:45-47